Summary by Moomoo AI
Gilead Sciences announced on November 20, 2024, the issuance of $3.5 billion in senior notes through four tranches: $750 million of 4.80% notes due 2029, $1 billion of 5.10% notes due 2035, $1 billion of 5.50% notes due 2054, and $750 million of 5.60% notes due 2064. The notes will pay interest semi-annually, with proceeds intended for general corporate purposes, including potential debt repayment.The company entered into a Tenth Supplemental Indenture with Computershare Trust Company, as trustee. The agreement includes restrictions on creating secured indebtedness, sale and leaseback transactions, and company consolidation or merger. Barclays Capital and BofA Securities acted as representatives for the underwriters in this public offering.
